The company's wholly-owned subsidiary, Nanomi BV has signed a definitive agreement for the acquisition. (Image Source: Unsplash) Show Quick Read Summary is AI Generated. Newsroom Reviewed

Lupin Ltd.'s subsidiary has finalised a deal to fully acquire Amsterdam-headquartered VISUfarma BV for 190 million euros, the company informed the exchanges on Monday. Lupin's share price gained nearly 1% on Monday to trade at Rs 1,925.60 apiece at intraday.

The company's wholly-owned subsidiary, Nanomi BV has signed a definitive agreement for the acquisition.

VISUfarma B.V. is headquartered in Amsterdam, the Netherlands. It is a specialty pharmaceutical company focused on ophthalmology. VISUfarma has a commercial presence across major European countries, including Italy, the UK, Spain, Germany an

See Full Page